Login to Your Account

Pharma: Other News To Note

Wednesday, October 23, 2013
• Samsung Biologics, of Seoul, South Korea, and Roche AG, of Basel, Switzerland, said they entered a long-term strategic manufacturing agreement under which Samsung will manufacture Roche’s commercial biologic medicines at its two manufacturing facilities in Incheon, South Korea.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription